A
Aurélie Velay
Researcher at University of Strasbourg
Publications - 59
Citations - 2830
Aurélie Velay is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Medicine & Serology. The author has an hindex of 14, co-authored 49 publications receiving 1080 citations. Previous affiliations of Aurélie Velay include University of Lorraine & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Delphine Planas,David Veyer,Artem Baidaliuk,Isabelle Staropoli,Florence Guivel-Benhassine,Maaran Michael Rajah,Maaran Michael Rajah,Cyril Planchais,Françoise Porrot,Nicolas Robillard,Julien Puech,Matthieu Prot,Floriane Gallais,Pierre Gantner,Aurélie Velay,Julien Le Guen,Najiby Kassis-Chikhani,Dhiaeddine Edriss,Laurent Bélec,Aymeric Sève,Laura Courtellemont,Hélène Péré,Laurent Hocqueloux,Samira Fafi-Kremer,Thierry Prazuck,Hugo Mouquet,Timothée Bruel,Etienne Simon-Loriere,Félix A. Rey,Olivier Schwartz +29 more
TL;DR: In this paper, an infectious strain of the SARS-CoV-2 Delta variant was isolated from an individual with COVID-19 who had returned to France from India.
Posted ContentDOI
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Delphine Planas,David Veyer,Artem Baidaliuk,Isabelle Staropoli,Florence Guivel-Benhassine,Maaran Michael Rajah,Maaran Michael Rajah,Cyril Planchais,Françoise Porrot,Nicolas Robillard,Julien Puech,Matthieu Prot,Floriane Gallais,Pierre Gantner,Aurélie Velay,Julien Le Guen,Najibi Kassis-Chikhani,Dhiaeddine Edriss,Laurent Bélec,Aymeric Sève,Hélène Péré,Laura Courtellemenont,Laurent Hocqueloux,Samira Fafi-Kremer,Thierry Prazuck,Hugo Mouquet,Timothée Bruel,Etienne Simon-Loriere,Félix A. Rey,Olivier Schwartz +29 more
TL;DR: The SARS-CoV-2 B.1.617 lineage emerged in October 2020 in India1-6.7.1 and has since then become dominant in some indian regions and further spread to many countries.
Journal ArticleDOI
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.
Floriane Gallais,Aurélie Velay,Charlotte Nazon,Marie Josée Wendling,Marialuisa Partisani,Jean Sibilia,Sophie Candon,Samira Fafi-Kremer,Samira Fafi-Kremer +8 more
TL;DR: Investigation of severe acute respiratory syndrome coronavirus 2–specific antibodies and T-cell responses against SARS-CoV-2 and human coronav virus 229E and OC43 in serodiscordant couples in Strasbourg, France suggests that exposure to SARS/HCoV can induce virus-specific T- cell responses without seroconversion.
Journal ArticleDOI
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
Floriane Gallais,Pierre Gantner,Timothée Bruel,Timothée Bruel,Aurélie Velay,Delphine Planas,Delphine Planas,Marie-Josée Wendling,Sophie Bayer,Morgane Solis,Elodie Laugel,Nathalie Reix,Anne Schneider,Ludovic Glady,Baptiste Panaget,Nicolas Collongues,Marialuisa Partisani,Jean-Marc Lessinger,Arnaud Fontanet,Arnaud Fontanet,David Rey,Yves Hansmann,Laurence Kling-Pillitteri,Olivier Schwartz,Olivier Schwartz,Jérôme De Seze,Nicolas Meyer,María González,Catherine Schmidt-Mutter,Samira Fafi-Kremer +29 more
TL;DR: In this article, a prospective, monocentric, longitudinal, cohort clinical study was conducted to assess the kinetics of SARS-CoV-2 antibodies and the incidence of reinfection.
Journal ArticleDOI
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Samira Fafi-Kremer,Timothée Bruel,Timothée Bruel,Yoann Madec,Rebecca Grant,Laura Tondeur,Ludivine Grzelak,Isabelle Staropoli,Isabelle Staropoli,François Anna,Philippe Souque,Sandrine Fernandes-Pellerin,Nathalie Jolly,Charlotte Renaudat,Marie-Noëlle Ungeheuer,Catherine Schmidt-Mutter,Nicolas Collongues,Alexandre Bolle,Aurélie Velay,Nicolas Lefebvre,Marie Mielcarek,Nicolas Meyer,David Rey,Pierre Charneau,Bruno Hoen,Jérôme De Seze,Olivier Schwartz,Olivier Schwartz,Arnaud Fontanet,Arnaud Fontanet +29 more
TL;DR: Antibodies against SARS-CoV-2 were detected in virtually all hospital staff sampled from 13 days after the onset of COVID-19 symptoms, and this finding supports the use of serologic testing for the diagnosis of individuals who have recovered from Sars-Cov-2 infection.